Serum phosphate measured at 6 and 12 months after successful kidney transplant is independently associated with subsequent graft loss

Experimental and Clinical Transplantation

Volumn 10, Issue 2, 2012, Pages 119-124

  Benavente, David ^a   Chue, Colin D ^a   Moore, Jason ^a   Addison, Clara ^a   Borrows, Richard ^a   Ferro, Charles J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Hyperphosphatemia; Hypophosphatemia; Phosphatonin

Indexed keywords

ALBUMIN; CREATININE; HLA ANTIGEN; PHOSPHATE; UREA;

ADULT; ALBUMINURIA; ARTICLE; BLOOD ANALYSIS; COHORT ANALYSIS; CREATININE URINE LEVEL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; HLA MATCHING; HUMAN; HYPERPHOSPHATEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL; PREDICTIVE VALUE;

ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; GRAFT SURVIVAL; HUMANS; HYPERPHOSPHATEMIA; HYPOPHOSPHATEMIA; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHOSPHATES; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS;

EID: 84859364431     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2011.0110     Document Type: Article

References (27)

1. Rosansky SJ, Sugimoto T. An analysis of the United States renal transplant patient population and organ survival characteristics: 1977 to 1980. Kidney Int. 1982;22(6):685-692.
2. Diethelm AG, Deierhoi MH, Hudson SL, et al. Progress in renal transplantation. A single center study of 3359 patients over 25 years. Ann Surg. 1995;221(5):446-457; discussion 457-458.
3. Olausson M, Blohmé I, Bäckman L, et al. Experience from a single institution: 3000 consecutive kidney transplants during 30 years. Transplant Proc. 1997;29(7):3096-3097.
4. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342(9):605-612.
5. Arend SM, Mallat MJ, Westendorp RJ, van der Woude FJ, van Es LA. Patient survival after renal transplantation; more than 25 years follow-up. Nephrol Dial Transplant. 1997;12(8):1672-1679.
6. Voormolen N, Noordzij M, Grootendorst DC, et al. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant. 2007;22(10):2909-2916.
7. Chue CD, Edwards NC, Davis LJ, Steeds RP, Townend JN, Ferro CJ. Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease. Nephrol Dial Transplant. 2011;26(8):2576-2582.
8. Moore J, Tomson CR, Tessa Savage M, Borrows R, Ferro CJ. Serum phosphate and calcium concentrations are associated with reduced patient survival following kidney transplantation. Clin Transplant. 2011;25(3):406-416.
9. Schaeffner ES, Födinger M, Kramar R, Sunder-Plassmann G, Winkelmayer WC. Prognostic associations of serum calcium, phosphate and calcium phosphate concentration product with outcomes in kidney transplant recipients. Transpl Int. 2007;20(3):247-255.
10. Egbuna OI, Taylor JG, Bushinsky DA, Zand MS. Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. Clin Transplant. 2007;21(4):558-566.
11. Roodnat JI, van Gurp EA, Mulder PG, et al. High pretransplant parathyroid hormone levels increase the risk for graft failure after renal transplantation. Transplantation. 2006;82(3):362-367.
12. Evenepoel P, Meijers BK, de Jonge H, et al. Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clin J Am Soc Nephrol. 2008;3(6):1829-1836.
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461-470.
14. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;(113):S1-S130.
15. Ferro CJ, Chue CD, Steeds RP, Townend JN. Is lowering phosphate exposure the key to preventing arterial stiffening with age? Heart. 2009;95(21):1770-1772.
16. Haut LL, Alfrey AC, Guggenheim S, Buddington B, Schrier N. Renal toxicity of phosphate in rats. Kidney Int. 1980;17(6):722-731.
17. Loghman-Adham M. Role of phosphate retention in the progression of renal failure. J Lab Clin Med. 1993;122(1):16-26.
18. Ibels LS, Alfrey AC, Haut L, Huffer WE. Preservation of function in experimental renal disease by dietary restriction of phosphate. N Engl J Med. 1978;298(3):122-126.
19. Cozzolino M, Staniforth ME, Liapis H, et al. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Kidney Int. 2003;64(5):1653-1661.
20. Nagano N, Miyata S, Obana S, et al. Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency. Nephrol Dial Transplant. 2003;18(10):2014-2023.
21. Stevens KK, Morgan IR, Patel RK, et al. Serum phosphate and outcome at one year after deceased donor renal transplantation. Clin Transplant. 2011;25(2):E199-E204.
22. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G; Cholesterol And Recurrent Events Trial Investigators. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005;112(17):2627-2633.
23. Kestenbaum B, Sampson JN, Rudser KD, et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol. 2005;16(2):520-528.
24. Connolly GM, Cunningham R, McNamee PT, Young IS, Maxwell AP. Elevated serum phosphate predicts mortality in renal transplant recipients. Transplantation. 2009;87(7):1040-1044.
25. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15(8):2208-2218.
26. Meier-Kriesche HU, Schold JD, Srinivas TR, Reed A, Kaplan B. Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant. 2004;4(10):1662-1668.
27. Matas AJ, Gillingham KJ, Humar A, et al. 2202 kidney transplant recipients with 10 years of graft function: what happens next? Am J Transplant. 2008;8(11):2410-2419.